Anzeige
Meldung des Tages: Freitagabend nachbörslich veröffentlicht – was der Markt erst am Montag sieht

Lucid Diagnostics Aktie News

Aktie
WKN:  ISIN:  US54948X1090 US-Symbol:  LUCD Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
1,19 $
+0,05 $
+4,39%
1,0042 € 30.01.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
36,90%
KGV
-2,43
Index-Zuordnung
-

Lucid Diagnostics News

21.01.26 - PR Newswire
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® PR Newswire
30.12.25 - PR Newswire
PAVmed Announces Reverse Stock Split
PAVmed Announces Reverse Stock Split PR Newswire
09.12.25 - PR Newswire
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-​World Experience of Esophageal Precancer Detection PR Newswire
20.11.25 - PR Newswire
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-​Ranking Honoree PR Newswire
13.11.25 - PR Newswire
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire
13.11.25 - PR Newswire
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire
12.11.25 - PR Newswire
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results PR Newswire
29.10.25 - PR Newswire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 PR Newswire
15.10.25 - PR Newswire
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit PR Newswire
25.09.25 - PR Newswire
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors PR Newswire
16.09.25 - PR Newswire
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs PR Newswire
11.09.25 - PR Newswire
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
Lucid Diagnostics Announces Closing of Public Offering of Common Stock PR Newswire
10.09.25 - PR Newswire
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock PR Newswire
09.09.25 - PR Newswire
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
Lucid Diagnostics Announces Proposed Public Offering of Common Stock PR Newswire
05.09.25 - PR Newswire
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 PR Newswire
27.08.25 - PR Newswire
Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025
Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025 PR Newswire
26.08.25 - PR Newswire
PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology
PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology PR Newswire
14.08.25 - PR Newswire
PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results
PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results PR Newswire
13.08.25 - PR Newswire
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results PR Newswire
05.08.25 - PR Newswire
Lucid Diagnostics to Participate in Upcoming Investor Conferences
Lucid Diagnostics to Participate in Upcoming Investor Conferences PR Newswire

Newssuche

Videos

newspaper
29.01.26 -10,12%
Rekordjagd bei Gold! Februar Ausblick & Forecast
Ab 2.2. (Montag) börsentäglich um 18 Uhr FEIERABEND-​TRADING. Echte Trades, strategiebasiert, ... Mehr »